Mycophenolic Acid-induced Replication Arrest, Differentiation Markers and Cell Death of Androgen-independent Prostate Cancer Cells DU145
Overview
Authors
Affiliations
Inosine 5'-monophosphate dehydrogenase inhibitors including mycophenolic acid (MPA) are effective inducers of terminal differentiation in a variety of distinct human tumor cell types. Here, we report that MPA also induces such a differentiation in the androgen-independent prostate cancer derived cell line DU145. MPA evoked replication arrest and accumulation of the DU145 cells in the S-phase of the cell cycle. The inhibitor also induced the expression of CD55, clusterin, granulophysin, glucose-regulated protein 78, vasoactive intestinal polypeptide and prostate-specific transglutaminase, which are differentiation markers associated with the phenotype of normal prostate cells. We suggest that inosine 5'-monophosphate dehydrogenase inhibitors, which are already used for the treatment of other diseases, may be used as potential differentiation therapy drugs to control prostate cancer.
Sanchez-Aguinagalde O, Sanchez-Rexach E, Polo Y, Larranaga A, Lejardi A, Meaurio E Polymers (Basel). 2024; 16(8).
PMID: 38675007 PMC: 11054924. DOI: 10.3390/polym16081088.
Sohbati H, Amini M, Balalaie S Iran J Pharm Res. 2023; 21(1):e129251.
PMID: 36942064 PMC: 10024327. DOI: 10.5812/ijpr-129251.
Reuse of Molecules for Glioblastoma Therapy.
Koehler A, Karve A, Desai P, Arbiser J, Plas D, Qi X Pharmaceuticals (Basel). 2021; 14(2).
PMID: 33525329 PMC: 7912673. DOI: 10.3390/ph14020099.
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N Cancers (Basel). 2019; 11(9).
PMID: 31514446 PMC: 6770829. DOI: 10.3390/cancers11091346.
Identifying drug-pathway association pairs based on L-integrative penalized matrix decomposition.
Liu J, Wang D, Zheng C, Gao Y, Wu S, Shang J BMC Syst Biol. 2018; 11(Suppl 6):119.
PMID: 29297378 PMC: 5770056. DOI: 10.1186/s12918-017-0480-7.